BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29320974)

  • 1. Head to head comparison of adverse effects and efficacy between high dose deflazacort and high dose prednisolone in systemic lupus erythematosus: a prospective cohort study.
    Ganapati A; Ravindran R; David T; Yadav B; Jeyaseelan V; Jeyaseelan L; Danda D
    Lupus; 2018 May; 27(6):890-898. PubMed ID: 29320974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long-term efficacy and safety of two different corticosteroids in chronic sarcoidosis.
    Rizzato G; Riboldi A; Imbimbo B; Torresin A; Milani S
    Respir Med; 1997 Sep; 91(8):449-60. PubMed ID: 9338047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled study of deflazacort in the treatment of idiopathic nephrotic syndrome.
    Broyer M; Terzi F; Lehnert A; Gagnadoux MF; Guest G; Niaudet P
    Pediatr Nephrol; 1997 Aug; 11(4):418-22. PubMed ID: 9260237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deflazacort induced stronger immunosuppression than expected.
    Gonzalez-Castañeda RE; Castellanos-Alvarado EA; Flores-Marquez MR; Gonzalez-Perez O; Luquin S; Garcia-Estrada J; Ramos-Remus C
    Clin Rheumatol; 2007 Jun; 26(6):935-40. PubMed ID: 16738843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two glucocorticoid preparations (deflazacort and prednisone) in the treatment of immune-mediated diseases.
    Scudeletti M; Puppo F; Lanza L; Mantovani L; Bosco O; Iudice A; Imbimbo B; Indiveri F
    Eur J Clin Pharmacol; 1993; 45 Suppl 1():S29-34. PubMed ID: 8313931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent effects of deflazacort and prednisone on growth and skeletal maturation.
    Aicardi G; Benso L; Vignolo M; Terragna A; Verrina E; Cordone G; Coppo R; Sernia O; Sardella ML; Di Battista E
    Br J Rheumatol; 1993 May; 32 Suppl 2():39-43. PubMed ID: 8495279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro improvement of chlorambucil-induced cytotoxicity by deflazacort and 6-methylprednisolone in B-cell chronic lymphocytic leukaemia.
    Morabito F; Callea I; Irrera G; Cartisano G; Dattola A; Rodinò A; Brugiatelli M
    Eur J Haematol; 1997 May; 58(5):301-6. PubMed ID: 9222284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of growth retarding effects induced by two different glucocorticoids in prepubertal sick children: an interim long-term analysis.
    Aicardi G; Milani S; Imbimbo B; Vignolo M; Di Battista E; Gusmano R; Terragna A; Cordone G; Cottafava F; Coppo R
    Calcif Tissue Int; 1991 Apr; 48(4):283-7. PubMed ID: 2059880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy.
    Griggs RC; Miller JP; Greenberg CR; Fehlings DL; Pestronk A; Mendell JR; Moxley RT; King W; Kissel JT; Cwik V; Vanasse M; Florence JM; Pandya S; Dubow JS; Meyer JM
    Neurology; 2016 Nov; 87(20):2123-2131. PubMed ID: 27566742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deflazacort in comparison to other steroids for nephrotic syndrome.
    Jat KR; Khairwa A
    Indian J Nephrol; 2012 Jul; 22(4):239-45. PubMed ID: 23162265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study.
    Floris A; Chessa E; Sebastiani GD; Prevete I; Iannone F; Coladonato L; Govoni M; Bortoluzzi A; Mosca M; Tani C; Doria A; Iaccarino L; Franceschini F; Fredi M; Conti F; Spinelli FR; Bellisai F; D'Alessandro R; Zanetti A; Carrara G; Scirè CA; Cauli A; Piga M;
    RMD Open; 2022 Dec; 8(2):. PubMed ID: 36581383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort.
    Olgaard K; Storm T; van Wowern N; Daugaard H; Egfjord M; Lewin E; Brandi L
    Calcif Tissue Int; 1992 Jun; 50(6):490-7. PubMed ID: 1525702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study.
    Bello L; Gordish-Dressman H; Morgenroth LP; Henricson EK; Duong T; Hoffman EP; Cnaan A; McDonald CM;
    Neurology; 2015 Sep; 85(12):1048-55. PubMed ID: 26311750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compared clinical efficacy and bone metabolic effects of low-dose deflazacort and methyl prednisolone in male inflammatory arthropathies: a 12-month open randomized pilot study.
    Saviola G; Abdi Ali L; Shams Eddin S; Coppini A; Cavalieri F; Campostrini L; Sacco S; Bucci M; Cirino G; Rossini M
    Rheumatology (Oxford); 2007 Jun; 46(6):994-8. PubMed ID: 17384176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary study of a traditional Chinese medicine formula in systemic lupus erythematosus patients to taper steroid dose and prevent disease flare-up.
    Liao YN; Liu CS; Tsai TR; Hung YC; Chang SJ; Lin HL; Chen YC; Lai HM; Yu SF; Chen CJ
    Kaohsiung J Med Sci; 2011 Jul; 27(7):251-7. PubMed ID: 21757141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with deflazacort in children and adolescents after renal transplantation.
    Schärer K; Feneberg R; Klaus G; Paschen C; Wüster C; Mehls O; Schaefer F
    Pediatr Nephrol; 2000 Jun; 14(6):457-63. PubMed ID: 10872183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of a degradation product of deflazacort.
    Paulino AS; Rauber G; Deobald AM; Paulino N; Sawaya AC; Eberlin MN; Cardoso SG
    Pharmazie; 2012 Jun; 67(6):495-9. PubMed ID: 22822536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potency ratio--a brief synopsis.
    Avioli LV
    Br J Rheumatol; 1993 May; 32 Suppl 2():24-6. PubMed ID: 8495276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statural growth and skeletal maturation in rheumatic prepubertal children treated with a third generation glucocorticoid (deflazacort) versus prednisone. An interim study.
    Vignolo M; Milani S; Imbimbo B; Naselli A; Di Battista E; Piaggio G; Leveratto L; Morreale G; Sardella ML; Corsini M
    Clin Exp Rheumatol; 1991; 9 Suppl 6():41-5. PubMed ID: 2060177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Inflammatory Effect of Deflazacort.
    Stellato C; Casolaro V; Renda A; Genovese A; Marone G
    Int Arch Allergy Immunol; 1992; 99(2-4):340-342. PubMed ID: 34167210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.